MENU
KLRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kalaris Therapeutics (KLRS) Earnings Date & Reports
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases... Show more
A.I. Advisor
published Earnings
KLRS is expected to report earnings to rise 18.22% to -54 cents per share on March 23
Q4'26
Est.
$-0.54
Q3'26
Beat
by $0.06
Q2'26
Beat
by $0.02
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.34
The last earnings report on November 10 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 55.55K shares outstanding, the current market capitalization sits at 57.61M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
400 Connell Drive
Phone
+1 650 249-2727
Employees
20
Web
https://www.kalaristx.com